Macleods Pharma Recalls 3,700 Blood Pressure Drug Bottles Over Failed Dissolution Tests
Updated
Updated · NBC Chicago · Nov 4
Macleods Pharma Recalls 3,700 Blood Pressure Drug Bottles Over Failed Dissolution Tests
3 articles · Updated · NBC Chicago · Nov 4
Summary
Macleods Pharma USA recalled 3,744 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets sold nationwide after FDA records showed the pills failed dissolution specifications.
The Oct. 7 recall covers blood pressure medicines in 40 mg, 10 mg and 12.5 mg strengths because the tablets did not break down and dissolve properly as required.
FDA classified the action as a Class II recall on Oct. 26, indicating the drugs could cause temporary or medically reversible health problems while serious consequences are considered unlikely.
The affected stock included 3,528 bottles with 30 tablets and 216 bottles with 90 tablets, underscoring a limited but nationwide quality-control issue for hypertension patients.